Drug intelligence / Profile preview

beta-cyclodextrin

Development stage
Preclinical
Lead developer
Roquette
Modality
Small Molecules
Administration
Oral, Intravenous, Topical, Ophthalmic
01

Overview

Beta-cyclodextrin is a cyclic oligosaccharide composed of seven D-glucopyranose units linked by alpha-1,4-glycosidic bonds. It is characterized by a truncated cone-shaped structure with a hydrophobic interior cavity and a hydrophilic exterior. This unique structure allows it to form non-covalent inclusion complexes with a wide variety of hydrophobic molecules, thereby improving their aqueous solubility, chemical stability, and bioavailability. While primarily utilized as a pharmaceutical excipient and food additive, beta-cyclodextrin and its derivatives are also explored for therapeutic roles, notably in the treatment of lipid storage disorders like Niemann-Pick disease type C, where they facilitate the egress of cholesterol from lysosomes. In research settings, it is frequently employed to develop targeted drug delivery systems, such as complexes designed to bypass efflux transporters in multidrug-resistant cancer cells.

Brand names
BetadexKleptoseCavamax W7
Other names
β-cyclodextrinCycloheptaamylosebeta-CDβ-CD

Beyond the preview

Go deeper on beta-cyclodextrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on beta-cyclodextrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call